Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
A central problem in the treatment of drug addiction is high rates of relapse to drug use after periods of forced or self-imposed abstinence. This relapse is often provoked by exposure to stress. Stress-induced relapse to drug seeking can be modeled in laboratory animals using a reinstatement procedure. In this procedure, drug-taking behaviors are extinguished and then reinstated by acute exposure to stressors like intermittent unpredictable footshock, restraint, food deprivation, and systemic injections of yohimbine, an alpha-2 adrenoceptor antagonist that induces stress-like responses in humans and nonhumans. For this special issue entitled “The role of neuropeptides in stress and addiction”, we review results from studies on the role of corticotropin-releasing factor (CRF) and several other peptides in stress-induced reinstatement of drug seeking in laboratory animals. The results of the studies reviewed indicate that extrahypothalamic CRF plays a critical role in stress-induced reinstatement of drug seeking; this role is largely independent of drug class, experimental procedure, and type of stressor. There is also limited evidence for the role of dynorphins, hypocretins (orexins), nociceptin (orphanin FQ), and leptin in stress-induced reinstatement of drug seeking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405 · cited 3×
“, 1995), leptin (Friedman and Halaas, 1998), neuropeptide Y (Tatemoto et al.”
BackgroundVale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878 · cited 2×
“First discovered in 1998, hypocretins (orexins) are neuropeptides synthesized by lateral hypothalamic and perifornical area neurons (de Lecea et al., 1998; Sakurai et al., 1998).”
BackgroundNeurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466 · cited 1×
“Hypocretin neurons project to neighboring hypothalamic nuclei, as well as to various forebrain,midbrain and brainstem areas (Peyron et al., 1998).”
BackgroundRole of leptin in the neuroendocrine response to fasting
Ahima, R. S., Prabakaran, D., Mantzoros, C., Qu, D., Lowell, B., Maratos-Flier, E., & Flier, J. S. (1996) · Nature · doi:10.1038/382250a0 · Cited by 3,117
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · cited 1×
“This term also refers to the human condition of resumption of old STRESS: A complex psychological construct that, despite many years of re operational definition (Chrousos and Gold, 1992; Cohen et al., 1982).”
BackgroundGut hormone PYY3-36 physiologically inhibits food intake
Batterham, R. L., Cowley, M. A., Small, C. J., Herzog, H., Cohen, M. A., Dakin, C. L., Wren, A. M., Brynes, A. E., Low, M. J., Ghatei, M. A., et al. (2002) · Nature · doi:10.1038/nature00887 · Cited by 2,351
Addiction motivation reformulated: an affective processing model of negative reinforcement
Baker, T. B., Piper, M. E., McCarthy, D. E., Majeskie, M. R., & Fiore, M. C. (2004) · Psychological Review · doi:10.1037/0033-295x.111.1.33 · Cited by 2,162
Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (2008) · Neuroendocrinology · doi:10.1159/000123454 · Cited by 1,953 · cited 1×
“CRF is known to be involved in behavioral and physiological stress responses via its actions on CRF receptors located in both hypothalamic and extrahypothalamic brain sites (de Souza, 1995; Dunn and Berridge, 1990; Swanson et al., 1983; Van Pett et al., 2000).”
BackgroundThe reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Self-citationInhibition of Food Intake in Obese Subjects by Peptide YY 3–36
Batterham, R. L., Cohen, M. A., Ellis, S. M., Le Roux, C. W., Withers, D. J., Frost, G. S., Ghatei, M. A., & Bloom, S. R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030204 · Cited by 1,604 · cited 1×
“There is evidence that systemic PYY3-36 injections decrease food intake inmice, rats, monkeys, and humans (Batterham et al., 2002, 2003; Moran et al., 2005, but see Boggiano et al., 2005).”
BackgroundHow does stress increase risk of drug abuse and relapse?
Sinha, R. (2001) · Psychopharmacology · doi:10.1007/s002130100917 · Cited by 1,505 · cited 1×
“Drug addiction is characterized by high rates of RELAPSE following prolonged periods of abstinence (Jaffe, 1990; O'Brien, 1997); this relapse is often provoked by exposure to STRESS (Baker et al., 2004; Sinha, 2001).”
BackgroundInfluentialDunn, A. J., & Berridge, C. W. (1990) · Brain Research Reviews · doi:10.1016/0165-0173(90)90012-d · Cited by 1,352
A role for lateral hypothalamic orexin neurons in reward seeking
Harris, G. C., Wimmer, M., & Aston-Jones, G. (2005) · Nature · doi:10.1038/nature04071 · Cited by 1,311 · cited 1×
“More recently, results from several studies implicate hypocretin's action in lateral hypothalamus and VTA in drug reward and in reinstatement of drug seeking (Borgland et al., 2006; Dayas et al., 2008; Hamlin et al., 2007; Harris et al., 2007, 2005; Lawrence et al., 2006; Narita et al., 2006).”
The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness
Sakurai, T. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2092 · Cited by 1,276
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 1×
“Results from many studies demonstrate an important role of CRF in both the aversive states of opiate, psychostimulant, alcohol, and nicotine withdrawal, and in dependence-induced increases in drug intake (Heilig and Koob, 2007; Koob, 2008; Sarnyai et al., 2001).”
BackgroundReinstatement of cocaine-reinforced responding in the rat
de Wit, H., & Stewart, J. (1981) · Psychopharmacology · doi:10.1007/bf00432175 · Cited by 928
Leptin Receptor Signaling in Midbrain Dopamine Neurons Regulates Feeding
Hommel, J. D., Trinko, R., Sears, R. M., Georgescu, D., Liu, Z.-W., Gao, X.-B., Thurmon, J. J., Marinelli, M., & DiLeone, R. J. (2006) · Neuron · doi:10.1016/j.neuron.2006.08.023 · Cited by 902
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880
Self-citationBorgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., & Bonci, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.016 · Cited by 718 · cited 1×
“More recently, results from several studies implicate hypocretin's action in lateral hypothalamus and VTA in drug reward and in reinstatement of drug seeking (Borgland et al., 2006; Dayas et al., 2008; Hamlin et al., 2007; Harris et al., 2007, 2005; Lawrence et al., 2006; Narita et al., 2006).”
Leptin Regulation of the Mesoaccumbens Dopamine Pathway
Fulton, S., Pissios, P., Manchon, R. P., Stiles, L., Frank, L., Pothos, E. N., Maratos-Flier, E., & Flier, J. S. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.006 · Cited by 644
Convergent regulation of locus coeruleus activity as an adaptive response to stress
Valentino, R. J., & Van Bockstaele, E. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.11.062 · Cited by 569
Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior
Boutrel, B., Kenny, P. J., Specio, S. E., Martin-Fardon, R., Markou, A., Koob, G. F., & de Lecea, L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507480102 · Cited by 520 · cited 2×
“In an initial study, Boutrel et al. (2005) reported that systemic injections of SB 334867 (a hypocretin type 1 receptor antagonist) attenuated footshock stress-induced reinstatement of cocaine seeking.”
BackgroundA key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503 · cited 1×
“Results from many studies demonstrate an important role of CRF in both the aversive states of opiate, psychostimulant, alcohol, and nicotine withdrawal, and in dependence-induced increases in drug intake (Heilig and Koob, 2007; Koob, 2008; Sarnyai et al., 2001).”
BackgroundOpposite Modulation of Cocaine-Seeking Behavior by D 1 - and D 2 -Like Dopamine Receptor Agonists
Self, D. W., Barnhart, W. J., Lehman, D. A., & Nestler, E. J. (1996) · Science · doi:10.1126/science.271.5255.1586 · Cited by 492 · cited 1×
“, food) afte reinstatement typically refers to the resumption of drug seeking after exti drugs (de Wit and Stewart, 1981; Self et al., 1996; Spealman et al., 1999), d Weiss et al.”
BackgroundWinsky-Sommerer, R., Yamanaka, A., Diano, S., Borok, E., Roberts, A. J., Sakurai, T., Kilduff, T. S., Horvath, T. L., & de Lecea, L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3459-04.2004 · Cited by 462 · cited 1×
“There is evidence for anatomical and functional interactions between the hypocretins and CRF, noradrenaline, and dopamine (Baldo et al., 2003; Bonci and Borgland, 2009; Boutrel, 2008; Winsky-Sommerer et al., 2004, 2005).”
BackgroundThe orexin system regulates alcohol-seeking in rats
Lawrence, A. J., Cowen, M. S., Yang, H., Chen, F., & Oldfield, B. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706789 · Cited by 392 · cited 1×
“More recently, results from several studies implicate hypocretin's action in lateral hypothalamus and VTA in drug reward and in reinstatement of drug seeking (Borgland et al., 2006; Dayas et al., 2008; Hamlin et al., 2007; Harris et al., 2007, 2005; Lawrence et al., 2006; Narita et al., 2006).”
Dynorphin and the pathophysiology of drug addiction
Shippenberg, T. S., Zapata, A., & Chefer, V. I. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.011 · Cited by 387 · cited 2×
“…that kappa receptor agonists inhibit (rather than potentiate) cocainepriming-induced reinstatement of lever responding (Schenk et al., 1999, 2000; Shippenberg et al., 2007) does not support the notion that activation of the dynorphin/kappa receptor system is critical for reinstatement of drug…”
BackgroundWang, B., Shaham, Y., Zitzman, D., Azari, S., Wise, R. A., & You, Z.-B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0955-05.2005 · Cited by 369
Self-citationThe neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358
Sakanaka, M., Shibasaki, T., & Lederis, K. (1986) · Brain Research · doi:10.1016/0006-8993(86)91332-6 · Cited by 337
Shaham, Y., Funk, D., Erb, S., Brown, T. J., Walker, C.-D., & Stewart, J. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02605.1997 · Cited by 308
Self-citationShaham, Y., Erb, S., Leung, S., Buczek, Y., & Stewart, J. (1998) · Psychopharmacology · doi:10.1007/s002130050608 · Cited by 302 · cited 1×
“Le et al. (2000) and Shaham et al. (1998) reported that systemic injections of CP-154,526 (a selective nonpeptide CRF1 receptor antagonist) decrease footshock-induced reinstatement of heroin, cocaine, and alcohol seeking.”
BackgroundSelf-citationSalmaso, N., Rodaros, D., Stewart, J., & Erb, S. (2001) · Psychopharmacology · doi:10.1007/s002130000642 · Cited by 291 · cited 6×
“In previous reviews, we and others summarized the literature on the neuropharmacology and neuroanatomy of stress-induced reinstatement of drug seeking (Aguilar et al., 2009; Bossert et al., 2005; Erb et al., 2001; Kalivas and McFarland, 2003; Shaham et al., 2000a; Shalev et al., 2002).”
BackgroundInfluentialSelf-citationAlpha-2 Adrenergic Receptor Agonists Block Stress-Induced Reinstatement of Cocaine Seeking
Erb, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00158-x · Cited by 270 · cited 2×
“Several years ago we proposed a neuroanatomical model of footshock-induced reinstatement of drug seeking (Erb et al., 2001; Shaham et al., 2000a) that was based on our early studies of the role of CRF (discussed above) and noradrenaline (Erb et al., 2000; Shaham et al., 2000b) in this reinstatement.”
BackgroundSelf-citationRichards, J. K., Simms, J. A., Steensland, P., Taha, S. A., Borgland, S. L., Bonci, A., & Bartlett, S. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1136-5 · Cited by 234 · cited 3×
“Alternatively, the discrepancy may be due to the use of different reinforcers: oral sucrose and alcohol solutions (Richards et al., 2008) versus 35% fat pellets (Nair et al.”
BackgroundShaham, Y., Highfield, D., Delfs, J., Leung, S., & Stewart, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00899.x · Cited by 201 · cited 7×
“In previous reviews, we and others summarized the literature on the neuropharmacology and neuroanatomy of stress-induced reinstatement of drug seeking (Aguilar et al., 2009; Bossert et al., 2005; Erb et al., 2001; Kalivas and McFarland, 2003; Shaham et al., 2000a; Shalev et al., 2002).”
BackgroundMethodInfluentialSelf-citationPotent Regulation of Midbrain Dopamine Neurons by the Bed Nucleus of the Stria Terminalis
Georges, F., & Aston-Jones, G. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-j0003.2001 · Cited by 163 · cited 1×
“Anatomical support for this model is provided by the identification of glutamate and CRF projection neurons from BNST to VTA (Georges and Aston-Jones, 2001; Georges and Aston-Jones, 2002; Rodaros et al., 2007).”
MethodSanchez, C. J., Bailie, T. M., Wu, W.-R., Li, N., & Sorg, B. A. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00078-2 · Cited by 160
Wang, J., Fang, Q., Liu, Z., & Lu, L. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0262-6 · Cited by 134 · cited 3×
“traint, conditioned fear, social defeat, swim stress, and tail pinch (Kreibich and Blendy, 2004; Ribeiro Do Couto et al., 2006; Sanchez and Sorg, 2001; Sanchez et al., 2003;Wang et al., 2006).”
BackgroundResultEconomidou, D., Hansson, A. C., Weiss, F., Terasmaa, A., Sommer, W. H., Cippitelli, A., Fedeli, A., Martin-Fardon, R., Massi, M., Ciccocioppo, R., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.02.004 · Cited by 120
Nair, S. G., Adams-Deutsch, T., Epstein, D. H., & Shaham, Y. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.05.003 · Cited by 112 · cited 1×
“More recently, results from several studies implicate hypocretin's action in lateral hypothalamus and VTA in drug reward and in reinstatement of drug seeking (Borgland et al., 2006; Dayas et al., 2008; Hamlin et al., 2007; Harris et al., 2007, 2005; Lawrence et al., 2006; Narita et al., 2006).”
Self-citationValdez, G. R., Platt, D. M., Rowlett, J. K., Rüedi-Bettschen, D., & Spealman, R. D. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.125484 · Cited by 99
Highfield, D. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00227-5 · Cited by 81
Leri, F., Tremblay, A., Sorge, R. E., & Stewart, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300435 · Cited by 80
Bonci, A., & Borgland, S. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.024 · Cited by 64 · cited 1×
“There is evidence for anatomical and functional interactions between the hypocretins and CRF, noradrenaline, and dopamine (Baldo et al., 2003; Bonci and Borgland, 2009; Boutrel, 2008; Winsky-Sommerer et al., 2004, 2005).”
BackgroundMaric, T., Tobin, S., Quinn, T., & Shalev, U. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.06.023 · Cited by 33
Self-citation
Cited by
The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544
“Due to these factors, several animal models have investigated the role of the CRF system in regulating stressinduced reinstatement and withdrawal behaviors (for a complete review see Shalev et al., 2009; Papaleo et al., 2007).”
BackgroundOpiate versus psychostimulant addiction: the differences do matter
Badiani, A., Belin, D., Epstein, D., Calu, D., & Shaham, Y. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3104 · Cited by 472
Self-citationStress-induced reinstatement of drug seeking: 20 years of progress
Mantsch, J. R., Baker, D. A., Funk, D., Lê, A. D., & Shaham, Y. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.142 · Cited by 438
Self-citationBossert, J. M., Marchant, N. J., Calu, D. J., & Shaham, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3120-y · Cited by 453
Self-citationPain, nicotine, and smoking: Research findings and mechanistic considerations.
Ditre, J. W., Brandon, T. H., Zale, E. L., & Meagher, M. M. (2011) · Psychological Bulletin · doi:10.1037/a0025544 · Cited by 342
Metadata
- Authors
- Shalev, U., Erb, S., & Shaham, Y.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 1314
- Pages
- 15-28
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2046127215
- Cited by
- 153
- References
- 48
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.